InvestorsHub Logo

jessellivermore

05/02/19 10:10 PM

#189835 RE: eboomer2611 #189833

eboomer...

Excellent post explaining the real ins and outs of selling shares or exercising options for biotech employees...It should be note the shares and options are not worth very much if the company does not perform..The current situation is far better than the employees who gain nothing from their shares or options...

Kennedy's sales might be annoying...But if the company was going down the tubes he would be in the same boat you are if the stock was worthless..

":>) JL

sts66

05/03/19 3:47 PM

#190049 RE: eboomer2611 #189833

I have no problem with what Berg did - what Kennedy does is what irks me - he always sells every share he acquires, doesn't keep any - from note 3 of his F4 from April 1 stock sales (not the latest one):

3. As previously reported on July 8, 2015, the Reporting Person was granted 755,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in 16 equal quarterly installments. The fifteenth vesting event occurred on March 31, 2019.



Kennedy has maintained a 31,260 share stake in AMRN for years, does not add to his pile, just wants the cash as soon as he can get it, which means he'll dump the last installment of RSUs on July 1 - that doesn't look good, regardless of the fact that he still has > 1M options available - they haven't vested yet so they're meaningless.

Just got my proxy vote materials this week, oddly from only one of my brokers - TDA didn't send them out (yet), looked but couldn't find a table of what the exec compensation committee thinks execs should be awarded this year after the 2011 Compensation Plan RSU's run out this June. We're being asked to vote to approve a new plan for which I cannot find info about - WTF? Is it there but I'm just missing it? All I can see is 2018 and prior stuff.